Latest Breaking News On - Zogenix inc - Page 6 : comparemela.com

Oncolytics Biotech Inc.: Oncolytics Biotech Appoints Jonathan Rigby to its Board of Directors

Mr. Rigby is the Group Chief Executive Officer of Revolo Biotherapeutics and has three decades of experience in the pharmaceutical and biotechnology industries SAN DIEGO and CALGARY, AB

Oncolytics Biotech® Appoints Jonathan Rigby to its Board of Directors

/PRNewswire/ Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced the appointment of Jonathan Rigby to its Board of Directors. "Jonathan has.

How Women Lead Strengthens Board Bench With Powerful Appointments -

$13.4+ Billion Global Needle-Free Diabetes Care Market Size Likely to Grow at 6.7% CAGR During 2022-2028 | Industry Trends, Share, Growth, SWOT Analysis, Forecast by Zion Market Research

/PRNewswire/ As per Zion Market Research study, The global needle-free diabetes care market size was worth USD 9.1 billion in 2021 and is estimated to grow.

At 3.5% CAGR, Global Epilepsy Therapeutics Market Size & Share To Surpass USD 18.1 Billion by 2028 | Industry Trends, Value, Analysis & Forecast Report by Zion Market Research

/PRNewswire/ As per Zion Market Research study, The global epilepsy therapeutics market was valued at over $13 billion in 2021 and is likely to surpass.